{"gene":"GATAD1","run_date":"2026-04-28T18:06:52","timeline":{"discoveries":[{"year":2011,"finding":"GATAD1 protein localizes to the nucleus of left ventricular myocytes, and a homozygous missense mutation (S102P) causes aberrant subcellular expression and nuclear morphology in cardiomyocytes, consistent with its role as a histone H3K4me3-interacting epigenetic regulator of gene expression.","method":"Immunohistochemistry demonstrating nuclear localization; exome sequencing and homozygosity mapping identifying pathogenic mutation; subcellular morphology analysis in patient tissue","journal":"Circulation. Cardiovascular genetics","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct localization by IHC with functional consequence (aberrant nuclear morphology in disease), single lab","pmids":["21965549"],"is_preprint":false},{"year":2008,"finding":"ODAG (mouse ortholog of GATAD1) physically binds Rab6-GTPase-activating protein (Rab6-GAP) and its substrate Rab6, as identified by pull-down assay coupled with mass spectrometry; overexpression of ODAG in the mouse eye disrupts Rab6/Rab6-GAP-mediated signaling, causing elevated intraocular pressure and impaired retinal development.","method":"Pull-down assay combined with mass spectrometry to identify binding partners; transgenic mouse overexpression with histological and IOP phenotypic analysis","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 3 — single pulldown/MS identification of binding partners with in vivo functional phenotype, single lab","pmids":["18791169"],"is_preprint":false},{"year":2016,"finding":"Zebrafish Gatad1 protein localizes to both the nucleus and sarcomeric I-band in cardiomyocytes; gatad1 knockout zebrafish develop heart failure-like phenotypes under stress, establishing a direct role for Gatad1 in maintaining cardiac function.","method":"Fluorescently-tagged Gatad1 Tol2 plasmid injection for subcellular localization; TALEN-mediated knockout with longitudinal cardiac phenotyping under stress","journal":"Journal of cardiovascular development and disease","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined cardiac phenotype and direct localization experiment, single lab","pmids":["28955713"],"is_preprint":false},{"year":2019,"finding":"GATAD1 acts as an epigenetic chromatin topological regulator that directly promotes CCND1 transcription by inducing long-range chromatin architectural interactions at the CCND1 promoter, thereby accelerating cell cycle progression and glioblastoma cell proliferation.","method":"ChIP-qPCR, EMSA, chromosome conformation capture (3C), cDNA microarray, and in vivo orthotopic tumor transplantation with GATAD1 knockdown","journal":"Cancer medicine","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (ChIP, EMSA, 3C) establishing direct transcriptional regulation mechanism, single lab","pmids":["31286678"],"is_preprint":false},{"year":2023,"finding":"GATAD1 promotes cell proliferation in ER+ breast cancer cells by transcriptionally inhibiting p21 (CDKN1A); GATAD1 depletion decreases phosphorylation of CDK2/4 and RB1, inducing G1 cell cycle arrest, and p21 overexpression abolishes the proliferative effect of GATAD1 overexpression.","method":"CRISPR synthetic lethality screen, siRNA knockdown, overexpression, cell cycle analysis, western blotting for CDK2/4 and RB1 phosphorylation, p21 rescue experiment","journal":"Medical oncology","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis via rescue experiment plus phosphorylation readouts, single lab","pmids":["37567972"],"is_preprint":false},{"year":2022,"finding":"GATAD1 transcriptionally activates SRRM2 expression in thyroid carcinoma cells; GATAD1-induced cell proliferation is dependent on increased SRRM2 expression, as SRRM2 knockdown abolishes GATAD1-driven proliferation.","method":"Knockdown and overexpression of GATAD1 with measurement of SRRM2 mRNA/protein levels; epistasis via SRRM2 knockdown rescue experiment; cell proliferation and cell cycle assays","journal":"Gland surgery","confidence":"Medium","confidence_rationale":"Tier 2-3 — genetic epistasis via rescue experiment establishing pathway position, single lab","pmids":["36654960"],"is_preprint":false},{"year":2024,"finding":"GATAD1 acts as a transcription factor in cardiomyocytes to inhibit fatty acid oxidation genes (Acaa2, Acadm) and promote glucose oxidation gene expression (Pdha1); cardiomyocyte-specific Gatad1 knockout worsens ischemia-reperfusion injury and abolishes SPC-mediated cardioprotection, while GATAD1 nuclear localization is regulated by sphingosylphosphorylcholine (SPC).","method":"Cardiomyocyte-specific conditional knockout mice, immunofluorescence and nuclear-cytoplasmic fractionation for localization, dual luciferase reporter assay, qPCR, siRNA/overexpression of downstream targets, in vivo I/R injury model","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 1-2 — conditional KO with defined metabolic phenotype, multiple orthogonal methods including reporter assay and fractionation, single lab","pmids":["39626862"],"is_preprint":false},{"year":2024,"finding":"Cardiomyocyte-specific deletion of Gatad1 in mice does not cause cardiomyopathy during aging up to 18 months or under pressure overload (TAC), and does not alter cardiomyocyte nuclear morphology, suggesting GATAD1 is not cell-autonomously required in murine cardiomyocytes for cardiac structural maintenance.","method":"Cardiomyocyte-specific Gatad1 cKO mouse model; cardiac function monitored longitudinally; TAC pressure overload stress model; nuclear morphology analysis","journal":"Journal of molecular histology","confidence":"Medium","confidence_rationale":"Tier 2 — clean cKO with defined phenotypic readouts, single lab, negative result","pmids":["39641830"],"is_preprint":false},{"year":2025,"finding":"GATAD1 regulates blood-brain barrier permeability in ischemic stroke by transcriptionally controlling CD36 expression in cerebral endothelial cells, thereby modulating caveolae-mediated transcytosis; endothelial-specific Gatad1 deletion reduces infarct volume and BBB dysfunction after experimental stroke.","method":"Endothelial cell-specific Gatad1 knockout mice; experimental ischemic stroke model; measurement of infarct volume and BBB permeability; mechanistic analysis of CD36 expression and caveolae-mediated transcytosis","journal":"Neuroscience bulletin","confidence":"Medium","confidence_rationale":"Tier 2 — cell-type-specific KO with defined molecular mechanism (CD36/caveolae) and functional phenotype, single lab","pmids":["40965809"],"is_preprint":false}],"current_model":"GATAD1 is a nuclear zinc finger transcription factor that interacts with H3K4me3 histone marks and regulates gene expression programs in multiple cell types: it promotes CCND1 transcription via long-range chromatin interactions, represses p21 to drive cell cycle progression, activates SRRM2 and inhibits fatty acid oxidation genes while promoting glucose oxidation genes in cardiomyocytes, and regulates CD36-dependent caveolae-mediated transcytosis in cerebral endothelial cells; its nuclear localization can be regulated by upstream signals (e.g., sphingosylphosphorylcholine), and it physically associates with Rab6-GAP and Rab6 in ocular tissues."},"narrative":{"teleology":[{"year":2008,"claim":"Identification of GATAD1 (ODAG) as a physical interactor of Rab6-GAP and Rab6 revealed an unexpected connection between this nuclear factor and vesicular trafficking machinery, with overexpression causing elevated intraocular pressure and retinal defects in mice.","evidence":"Pull-down/mass spectrometry for binding partners; transgenic mouse overexpression with IOP and histological phenotyping","pmids":["18791169"],"confidence":"Medium","gaps":["Interaction identified by single pulldown/MS without reciprocal validation","Whether the Rab6-GAP interaction reflects a physiological nuclear-independent function or an overexpression artifact is unclear","No mechanism linking GATAD1-Rab6 interaction to the intraocular pressure phenotype"]},{"year":2011,"claim":"The discovery that a homozygous GATAD1 S102P mutation causes dilated cardiomyopathy established GATAD1 as a disease gene and linked its nuclear localization and H3K4me3-reading function to cardiac pathology.","evidence":"Exome sequencing and homozygosity mapping in consanguineous family; IHC for nuclear localization in left ventricular myocytes","pmids":["21965549"],"confidence":"Medium","gaps":["Mechanism by which S102P disrupts GATAD1 function not defined at the molecular level","Whether the aberrant subcellular distribution is cause or consequence of cardiomyopathy not resolved","No rescue or complementation experiment performed"]},{"year":2016,"claim":"Zebrafish gatad1 knockout confirmed a conserved requirement for Gatad1 in cardiac function under stress, while localization studies revealed both nuclear and sarcomeric I-band distribution in cardiomyocytes.","evidence":"TALEN-mediated knockout in zebrafish with cardiac phenotyping; fluorescent tagging for subcellular localization","pmids":["28955713"],"confidence":"Medium","gaps":["The functional significance of sarcomeric I-band localization is unknown","Whether the zebrafish cardiac phenotype maps to the same transcriptional targets as in mammals is untested","Stress-dependent phenotype leaves open whether GATAD1 is required for basal cardiac maintenance"]},{"year":2019,"claim":"Demonstration that GATAD1 directly binds the CCND1 promoter and induces long-range chromatin interactions to activate cyclin D1 transcription established the first detailed transcriptional mechanism for GATAD1's pro-proliferative activity.","evidence":"ChIP-qPCR, EMSA, chromosome conformation capture (3C), and orthotopic GBM tumor model with GATAD1 knockdown","pmids":["31286678"],"confidence":"High","gaps":["Whether GATAD1 recruits specific chromatin remodelers or coactivators to mediate looping is unknown","Genome-wide binding profile (ChIP-seq) for GATAD1 has not been reported","Generalizability of the chromatin looping mechanism beyond the CCND1 locus not tested"]},{"year":2022,"claim":"Identification of SRRM2 as a direct transcriptional target of GATAD1 whose expression is required for GATAD1-driven proliferation expanded the set of downstream effectors beyond cell cycle regulators.","evidence":"Knockdown/overexpression epistasis with SRRM2 rescue in thyroid carcinoma cells; proliferation and cell cycle assays","pmids":["36654960"],"confidence":"Medium","gaps":["Whether GATAD1 directly binds the SRRM2 promoter or acts indirectly is not shown","The downstream mechanism linking SRRM2 (a splicing factor) to proliferation in this context is uncharacterized","Single lab, single cancer cell type"]},{"year":2023,"claim":"The finding that GATAD1 represses p21/CDKN1A to maintain CDK2/4-RB1 phosphorylation revealed a complementary cell cycle mechanism — activation of CCND1 plus repression of a CDK inhibitor — explaining its potent pro-proliferative function.","evidence":"siRNA knockdown and overexpression in ER+ breast cancer cells; p21 rescue experiment; western blot for CDK/RB1 phosphorylation","pmids":["37567972"],"confidence":"Medium","gaps":["Whether GATAD1 directly binds the CDKN1A promoter or represses through an intermediate is not determined","Relationship between CCND1 activation and p21 repression in the same cell type not tested","In vivo validation of the p21-dependent proliferative mechanism is lacking"]},{"year":2024,"claim":"Conditional knockout in cardiomyocytes established GATAD1 as a metabolic transcriptional switch — repressing fatty acid oxidation and promoting glucose oxidation — and showed that SPC controls GATAD1 nuclear localization, providing the first signal-regulated mechanism for GATAD1 activity.","evidence":"Cardiomyocyte-specific Gatad1 cKO mice; I/R injury model; luciferase reporters for target gene promoters; nuclear/cytoplasmic fractionation for SPC-regulated translocation","pmids":["39626862"],"confidence":"High","gaps":["The molecular mechanism by which SPC promotes GATAD1 nuclear import (receptor, kinase, NLS modification) is unresolved","Whether GATAD1 directly binds FAO gene promoters or acts through an intermediary is not fully established","Metabolic flux measurements to confirm the shift from FAO to glucose oxidation are not reported"]},{"year":2024,"claim":"A parallel cardiomyocyte-specific Gatad1 cKO study found no cardiomyopathy during aging or pressure overload, challenging the notion that GATAD1 is cell-autonomously required for murine cardiac structural maintenance and raising questions about species or context differences with the human disease.","evidence":"Cardiomyocyte-specific Gatad1 cKO with longitudinal cardiac monitoring to 18 months and TAC stress model","pmids":["39641830"],"confidence":"Medium","gaps":["Discrepancy between this negative result and the I/R injury phenotype from a contemporaneous study is unreconciled","Whether murine cardiomyocytes compensate through redundant factors is unknown","Does not address non-cell-autonomous cardiac contributions (e.g., endothelial or fibroblast GATAD1)"]},{"year":2025,"claim":"Discovery that GATAD1 controls blood-brain barrier integrity by transcriptionally regulating CD36 and caveolae-mediated transcytosis in endothelial cells extended GATAD1's role beyond proliferation and metabolism to vascular barrier function.","evidence":"Endothelial-specific Gatad1 cKO mice with experimental ischemic stroke; BBB permeability and infarct volume measurements; CD36/caveolae mechanistic analysis","pmids":["40965809"],"confidence":"Medium","gaps":["Whether GATAD1 directly binds the CD36 promoter is not confirmed by ChIP","Role of GATAD1 in BBB homeostasis under non-ischemic conditions is not established","Whether the BBB phenotype generalizes beyond stroke to neuroinflammation or neurodegeneration is unknown"]},{"year":null,"claim":"The genome-wide binding landscape of GATAD1, the structural basis for its H3K4me3 recognition, the identity of its co-regulatory partners at different target loci, and the signal transduction pathway linking SPC to GATAD1 nuclear translocation remain undefined.","evidence":"","pmids":[],"confidence":"Low","gaps":["No ChIP-seq or CUT&RUN genome-wide binding data reported","No crystal structure or cryo-EM of GATAD1 bound to modified histones","Upstream signaling from SPC to GATAD1 nuclear import is mechanistically uncharacterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[3,4,5,6,8]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[0,3]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2,6]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,3]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,4,5,6,8]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[3,4]}],"complexes":[],"partners":["CCND1","CDKN1A","SRRM2","CD36","RAB6A","TBC1D11"],"other_free_text":[]},"mechanistic_narrative":"GATAD1 is a nuclear chromatin-associated transcription factor that reads H3K4me3 histone marks and regulates diverse gene expression programs controlling cell proliferation, cardiac metabolism, and vascular barrier function. In proliferating cells, GATAD1 promotes cell cycle progression by inducing long-range chromatin interactions at the CCND1 promoter to activate cyclin D1 transcription and by transcriptionally repressing the CDK inhibitor p21 (CDKN1A), thereby sustaining CDK2/4-RB1 phosphorylation [PMID:31286678, PMID:37567972]. In cardiomyocytes, GATAD1 functions as a metabolic transcriptional switch that inhibits fatty acid oxidation genes (Acaa2, Acadm) while promoting glucose oxidation (Pdha1), with its nuclear translocation regulated by sphingosylphosphorylcholine; a homozygous S102P missense mutation in GATAD1 causes autosomal-recessive dilated cardiomyopathy [PMID:39626862, PMID:21965549]. In cerebral endothelial cells, GATAD1 transcriptionally controls CD36 to regulate caveolae-mediated transcytosis and blood-brain barrier permeability during ischemic stroke [PMID:40965809]."},"prefetch_data":{"uniprot":{"accession":"Q8WUU5","full_name":"GATA zinc finger domain-containing protein 1","aliases":["Ocular development-associated gene protein"],"length_aa":269,"mass_kda":28.7,"function":"Component of some chromatin complex recruited to chromatin sites methylated 'Lys-4' of histone H3 (H3K4me), with a preference for trimethylated form (H3K4me3)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8WUU5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GATAD1","classification":"Not Classified","n_dependent_lines":90,"n_total_lines":1208,"dependency_fraction":0.07450331125827815},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000157259","cell_line_id":"CID001603","localizations":[{"compartment":"nucleoplasm","grade":3},{"compartment":"chromatin","grade":2}],"interactors":[{"gene":"SRPR","stoichiometry":10.0},{"gene":"PHF12","stoichiometry":4.0},{"gene":"EMSY;C11ORF30","stoichiometry":4.0},{"gene":"ARL8A","stoichiometry":0.2},{"gene":"ARL8B","stoichiometry":0.2},{"gene":"KDM5A","stoichiometry":0.2},{"gene":"HIST2H2BE","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001603","total_profiled":1310},"omim":[{"mim_id":"614672","title":"CARDIOMYOPATHY, DILATED, 2B; CMD2B","url":"https://www.omim.org/entry/614672"},{"mim_id":"614518","title":"GATA ZINC FINGER DOMAIN-CONTAINING PROTEIN 1; GATAD1","url":"https://www.omim.org/entry/614518"},{"mim_id":"115200","title":"CARDIOMYOPATHY, DILATED, 1A; CMD1A","url":"https://www.omim.org/entry/115200"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GATAD1"},"hgnc":{"alias_symbol":["ODAG","RG083M05.2","FLJ22489"],"prev_symbol":[]},"alphafold":{"accession":"Q8WUU5","domains":[{"cath_id":"2.30.30.490","chopping":"138-224","consensus_level":"high","plddt":93.2425,"start":138,"end":224},{"cath_id":"3.30.60","chopping":"2-36","consensus_level":"medium","plddt":83.4629,"start":2,"end":36}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WUU5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WUU5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WUU5-F1-predicted_aligned_error_v6.png","plddt_mean":70.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GATAD1","jax_strain_url":"https://www.jax.org/strain/search?query=GATAD1"},"sequence":{"accession":"Q8WUU5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8WUU5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8WUU5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WUU5"}},"corpus_meta":[{"pmid":"21965549","id":"PMC_21965549","title":"Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy.","date":"2011","source":"Circulation. Cardiovascular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21965549","citation_count":57,"is_preprint":false},{"pmid":"24462704","id":"PMC_24462704","title":"Decreased expression and DNA methylation levels of GATAD1 in preeclamptic placentas.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/24462704","citation_count":13,"is_preprint":false},{"pmid":"28955713","id":"PMC_28955713","title":"Modeling GATAD1-Associated Dilated Cardiomyopathy in Adult Zebrafish.","date":"2016","source":"Journal of cardiovascular development and disease","url":"https://pubmed.ncbi.nlm.nih.gov/28955713","citation_count":13,"is_preprint":false},{"pmid":"12062807","id":"PMC_12062807","title":"Ocular development-associated gene (ODAG), a novel gene highly expressed in ocular development.","date":"2002","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/12062807","citation_count":9,"is_preprint":false},{"pmid":"31286678","id":"PMC_31286678","title":"GATAD1 gene amplification promotes glioma malignancy by directly regulating CCND1 transcription.","date":"2019","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31286678","citation_count":8,"is_preprint":false},{"pmid":"39626862","id":"PMC_39626862","title":"GATAD1 is involved in sphingosylphosphorylcholine-attenuated myocardial ischemia-reperfusion injury by modulating myocardial fatty acid oxidation and glucose oxidation.","date":"2024","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39626862","citation_count":7,"is_preprint":false},{"pmid":"38443846","id":"PMC_38443846","title":"Knockdown of circ-Gatad1 alleviates LPS induced HK2 cell injury via targeting miR-22-3p/TRPM7 axis in septic acute kidney.","date":"2024","source":"BMC nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/38443846","citation_count":6,"is_preprint":false},{"pmid":"18791169","id":"PMC_18791169","title":"Elevated intraocular pressure, optic nerve atrophy, and impaired retinal development in ODAG transgenic mice.","date":"2008","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/18791169","citation_count":5,"is_preprint":false},{"pmid":"37567972","id":"PMC_37567972","title":"CRISPR screen identifies GATAD1 as a synthetic lethal target with CDK4/6 inhibitors in estrogen receptor-positive breast cancer.","date":"2023","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/37567972","citation_count":2,"is_preprint":false},{"pmid":"36654960","id":"PMC_36654960","title":"Effect of GATAD1 regulating the SRRM2 gene on recurrence of thyroid tumor and its molecular mechanism.","date":"2022","source":"Gland surgery","url":"https://pubmed.ncbi.nlm.nih.gov/36654960","citation_count":1,"is_preprint":false},{"pmid":"39641830","id":"PMC_39641830","title":"Loss of GATAD1 in cardiomyocyte does not cause cardiomyopathy in mice.","date":"2024","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/39641830","citation_count":1,"is_preprint":false},{"pmid":"40965809","id":"PMC_40965809","title":"Endothelial GATAD1 Exacerbates Blood-brain Barrier Dysfunction in Ischemic Stroke through Caveolae-mediated Transcytosis.","date":"2025","source":"Neuroscience bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/40965809","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7408,"output_tokens":2304,"usd":0.028392},"stage2":{"model":"claude-opus-4-6","input_tokens":5593,"output_tokens":2889,"usd":0.150285},"total_usd":0.178677,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"GATAD1 protein localizes to the nucleus of left ventricular myocytes, and a homozygous missense mutation (S102P) causes aberrant subcellular expression and nuclear morphology in cardiomyocytes, consistent with its role as a histone H3K4me3-interacting epigenetic regulator of gene expression.\",\n      \"method\": \"Immunohistochemistry demonstrating nuclear localization; exome sequencing and homozygosity mapping identifying pathogenic mutation; subcellular morphology analysis in patient tissue\",\n      \"journal\": \"Circulation. Cardiovascular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization by IHC with functional consequence (aberrant nuclear morphology in disease), single lab\",\n      \"pmids\": [\"21965549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"ODAG (mouse ortholog of GATAD1) physically binds Rab6-GTPase-activating protein (Rab6-GAP) and its substrate Rab6, as identified by pull-down assay coupled with mass spectrometry; overexpression of ODAG in the mouse eye disrupts Rab6/Rab6-GAP-mediated signaling, causing elevated intraocular pressure and impaired retinal development.\",\n      \"method\": \"Pull-down assay combined with mass spectrometry to identify binding partners; transgenic mouse overexpression with histological and IOP phenotypic analysis\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single pulldown/MS identification of binding partners with in vivo functional phenotype, single lab\",\n      \"pmids\": [\"18791169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Zebrafish Gatad1 protein localizes to both the nucleus and sarcomeric I-band in cardiomyocytes; gatad1 knockout zebrafish develop heart failure-like phenotypes under stress, establishing a direct role for Gatad1 in maintaining cardiac function.\",\n      \"method\": \"Fluorescently-tagged Gatad1 Tol2 plasmid injection for subcellular localization; TALEN-mediated knockout with longitudinal cardiac phenotyping under stress\",\n      \"journal\": \"Journal of cardiovascular development and disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cardiac phenotype and direct localization experiment, single lab\",\n      \"pmids\": [\"28955713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GATAD1 acts as an epigenetic chromatin topological regulator that directly promotes CCND1 transcription by inducing long-range chromatin architectural interactions at the CCND1 promoter, thereby accelerating cell cycle progression and glioblastoma cell proliferation.\",\n      \"method\": \"ChIP-qPCR, EMSA, chromosome conformation capture (3C), cDNA microarray, and in vivo orthotopic tumor transplantation with GATAD1 knockdown\",\n      \"journal\": \"Cancer medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (ChIP, EMSA, 3C) establishing direct transcriptional regulation mechanism, single lab\",\n      \"pmids\": [\"31286678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GATAD1 promotes cell proliferation in ER+ breast cancer cells by transcriptionally inhibiting p21 (CDKN1A); GATAD1 depletion decreases phosphorylation of CDK2/4 and RB1, inducing G1 cell cycle arrest, and p21 overexpression abolishes the proliferative effect of GATAD1 overexpression.\",\n      \"method\": \"CRISPR synthetic lethality screen, siRNA knockdown, overexpression, cell cycle analysis, western blotting for CDK2/4 and RB1 phosphorylation, p21 rescue experiment\",\n      \"journal\": \"Medical oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via rescue experiment plus phosphorylation readouts, single lab\",\n      \"pmids\": [\"37567972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GATAD1 transcriptionally activates SRRM2 expression in thyroid carcinoma cells; GATAD1-induced cell proliferation is dependent on increased SRRM2 expression, as SRRM2 knockdown abolishes GATAD1-driven proliferation.\",\n      \"method\": \"Knockdown and overexpression of GATAD1 with measurement of SRRM2 mRNA/protein levels; epistasis via SRRM2 knockdown rescue experiment; cell proliferation and cell cycle assays\",\n      \"journal\": \"Gland surgery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — genetic epistasis via rescue experiment establishing pathway position, single lab\",\n      \"pmids\": [\"36654960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GATAD1 acts as a transcription factor in cardiomyocytes to inhibit fatty acid oxidation genes (Acaa2, Acadm) and promote glucose oxidation gene expression (Pdha1); cardiomyocyte-specific Gatad1 knockout worsens ischemia-reperfusion injury and abolishes SPC-mediated cardioprotection, while GATAD1 nuclear localization is regulated by sphingosylphosphorylcholine (SPC).\",\n      \"method\": \"Cardiomyocyte-specific conditional knockout mice, immunofluorescence and nuclear-cytoplasmic fractionation for localization, dual luciferase reporter assay, qPCR, siRNA/overexpression of downstream targets, in vivo I/R injury model\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — conditional KO with defined metabolic phenotype, multiple orthogonal methods including reporter assay and fractionation, single lab\",\n      \"pmids\": [\"39626862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cardiomyocyte-specific deletion of Gatad1 in mice does not cause cardiomyopathy during aging up to 18 months or under pressure overload (TAC), and does not alter cardiomyocyte nuclear morphology, suggesting GATAD1 is not cell-autonomously required in murine cardiomyocytes for cardiac structural maintenance.\",\n      \"method\": \"Cardiomyocyte-specific Gatad1 cKO mouse model; cardiac function monitored longitudinally; TAC pressure overload stress model; nuclear morphology analysis\",\n      \"journal\": \"Journal of molecular histology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean cKO with defined phenotypic readouts, single lab, negative result\",\n      \"pmids\": [\"39641830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GATAD1 regulates blood-brain barrier permeability in ischemic stroke by transcriptionally controlling CD36 expression in cerebral endothelial cells, thereby modulating caveolae-mediated transcytosis; endothelial-specific Gatad1 deletion reduces infarct volume and BBB dysfunction after experimental stroke.\",\n      \"method\": \"Endothelial cell-specific Gatad1 knockout mice; experimental ischemic stroke model; measurement of infarct volume and BBB permeability; mechanistic analysis of CD36 expression and caveolae-mediated transcytosis\",\n      \"journal\": \"Neuroscience bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with defined molecular mechanism (CD36/caveolae) and functional phenotype, single lab\",\n      \"pmids\": [\"40965809\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GATAD1 is a nuclear zinc finger transcription factor that interacts with H3K4me3 histone marks and regulates gene expression programs in multiple cell types: it promotes CCND1 transcription via long-range chromatin interactions, represses p21 to drive cell cycle progression, activates SRRM2 and inhibits fatty acid oxidation genes while promoting glucose oxidation genes in cardiomyocytes, and regulates CD36-dependent caveolae-mediated transcytosis in cerebral endothelial cells; its nuclear localization can be regulated by upstream signals (e.g., sphingosylphosphorylcholine), and it physically associates with Rab6-GAP and Rab6 in ocular tissues.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GATAD1 is a nuclear chromatin-associated transcription factor that reads H3K4me3 histone marks and regulates diverse gene expression programs controlling cell proliferation, cardiac metabolism, and vascular barrier function. In proliferating cells, GATAD1 promotes cell cycle progression by inducing long-range chromatin interactions at the CCND1 promoter to activate cyclin D1 transcription and by transcriptionally repressing the CDK inhibitor p21 (CDKN1A), thereby sustaining CDK2/4-RB1 phosphorylation [PMID:31286678, PMID:37567972]. In cardiomyocytes, GATAD1 functions as a metabolic transcriptional switch that inhibits fatty acid oxidation genes (Acaa2, Acadm) while promoting glucose oxidation (Pdha1), with its nuclear translocation regulated by sphingosylphosphorylcholine; a homozygous S102P missense mutation in GATAD1 causes autosomal-recessive dilated cardiomyopathy [PMID:39626862, PMID:21965549]. In cerebral endothelial cells, GATAD1 transcriptionally controls CD36 to regulate caveolae-mediated transcytosis and blood-brain barrier permeability during ischemic stroke [PMID:40965809].\",\n  \"teleology\": [\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of GATAD1 (ODAG) as a physical interactor of Rab6-GAP and Rab6 revealed an unexpected connection between this nuclear factor and vesicular trafficking machinery, with overexpression causing elevated intraocular pressure and retinal defects in mice.\",\n      \"evidence\": \"Pull-down/mass spectrometry for binding partners; transgenic mouse overexpression with IOP and histological phenotyping\",\n      \"pmids\": [\"18791169\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Interaction identified by single pulldown/MS without reciprocal validation\",\n        \"Whether the Rab6-GAP interaction reflects a physiological nuclear-independent function or an overexpression artifact is unclear\",\n        \"No mechanism linking GATAD1-Rab6 interaction to the intraocular pressure phenotype\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The discovery that a homozygous GATAD1 S102P mutation causes dilated cardiomyopathy established GATAD1 as a disease gene and linked its nuclear localization and H3K4me3-reading function to cardiac pathology.\",\n      \"evidence\": \"Exome sequencing and homozygosity mapping in consanguineous family; IHC for nuclear localization in left ventricular myocytes\",\n      \"pmids\": [\"21965549\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which S102P disrupts GATAD1 function not defined at the molecular level\",\n        \"Whether the aberrant subcellular distribution is cause or consequence of cardiomyopathy not resolved\",\n        \"No rescue or complementation experiment performed\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Zebrafish gatad1 knockout confirmed a conserved requirement for Gatad1 in cardiac function under stress, while localization studies revealed both nuclear and sarcomeric I-band distribution in cardiomyocytes.\",\n      \"evidence\": \"TALEN-mediated knockout in zebrafish with cardiac phenotyping; fluorescent tagging for subcellular localization\",\n      \"pmids\": [\"28955713\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The functional significance of sarcomeric I-band localization is unknown\",\n        \"Whether the zebrafish cardiac phenotype maps to the same transcriptional targets as in mammals is untested\",\n        \"Stress-dependent phenotype leaves open whether GATAD1 is required for basal cardiac maintenance\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstration that GATAD1 directly binds the CCND1 promoter and induces long-range chromatin interactions to activate cyclin D1 transcription established the first detailed transcriptional mechanism for GATAD1's pro-proliferative activity.\",\n      \"evidence\": \"ChIP-qPCR, EMSA, chromosome conformation capture (3C), and orthotopic GBM tumor model with GATAD1 knockdown\",\n      \"pmids\": [\"31286678\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether GATAD1 recruits specific chromatin remodelers or coactivators to mediate looping is unknown\",\n        \"Genome-wide binding profile (ChIP-seq) for GATAD1 has not been reported\",\n        \"Generalizability of the chromatin looping mechanism beyond the CCND1 locus not tested\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of SRRM2 as a direct transcriptional target of GATAD1 whose expression is required for GATAD1-driven proliferation expanded the set of downstream effectors beyond cell cycle regulators.\",\n      \"evidence\": \"Knockdown/overexpression epistasis with SRRM2 rescue in thyroid carcinoma cells; proliferation and cell cycle assays\",\n      \"pmids\": [\"36654960\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether GATAD1 directly binds the SRRM2 promoter or acts indirectly is not shown\",\n        \"The downstream mechanism linking SRRM2 (a splicing factor) to proliferation in this context is uncharacterized\",\n        \"Single lab, single cancer cell type\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The finding that GATAD1 represses p21/CDKN1A to maintain CDK2/4-RB1 phosphorylation revealed a complementary cell cycle mechanism — activation of CCND1 plus repression of a CDK inhibitor — explaining its potent pro-proliferative function.\",\n      \"evidence\": \"siRNA knockdown and overexpression in ER+ breast cancer cells; p21 rescue experiment; western blot for CDK/RB1 phosphorylation\",\n      \"pmids\": [\"37567972\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether GATAD1 directly binds the CDKN1A promoter or represses through an intermediate is not determined\",\n        \"Relationship between CCND1 activation and p21 repression in the same cell type not tested\",\n        \"In vivo validation of the p21-dependent proliferative mechanism is lacking\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Conditional knockout in cardiomyocytes established GATAD1 as a metabolic transcriptional switch — repressing fatty acid oxidation and promoting glucose oxidation — and showed that SPC controls GATAD1 nuclear localization, providing the first signal-regulated mechanism for GATAD1 activity.\",\n      \"evidence\": \"Cardiomyocyte-specific Gatad1 cKO mice; I/R injury model; luciferase reporters for target gene promoters; nuclear/cytoplasmic fractionation for SPC-regulated translocation\",\n      \"pmids\": [\"39626862\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The molecular mechanism by which SPC promotes GATAD1 nuclear import (receptor, kinase, NLS modification) is unresolved\",\n        \"Whether GATAD1 directly binds FAO gene promoters or acts through an intermediary is not fully established\",\n        \"Metabolic flux measurements to confirm the shift from FAO to glucose oxidation are not reported\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"A parallel cardiomyocyte-specific Gatad1 cKO study found no cardiomyopathy during aging or pressure overload, challenging the notion that GATAD1 is cell-autonomously required for murine cardiac structural maintenance and raising questions about species or context differences with the human disease.\",\n      \"evidence\": \"Cardiomyocyte-specific Gatad1 cKO with longitudinal cardiac monitoring to 18 months and TAC stress model\",\n      \"pmids\": [\"39641830\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Discrepancy between this negative result and the I/R injury phenotype from a contemporaneous study is unreconciled\",\n        \"Whether murine cardiomyocytes compensate through redundant factors is unknown\",\n        \"Does not address non-cell-autonomous cardiac contributions (e.g., endothelial or fibroblast GATAD1)\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that GATAD1 controls blood-brain barrier integrity by transcriptionally regulating CD36 and caveolae-mediated transcytosis in endothelial cells extended GATAD1's role beyond proliferation and metabolism to vascular barrier function.\",\n      \"evidence\": \"Endothelial-specific Gatad1 cKO mice with experimental ischemic stroke; BBB permeability and infarct volume measurements; CD36/caveolae mechanistic analysis\",\n      \"pmids\": [\"40965809\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether GATAD1 directly binds the CD36 promoter is not confirmed by ChIP\",\n        \"Role of GATAD1 in BBB homeostasis under non-ischemic conditions is not established\",\n        \"Whether the BBB phenotype generalizes beyond stroke to neuroinflammation or neurodegeneration is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The genome-wide binding landscape of GATAD1, the structural basis for its H3K4me3 recognition, the identity of its co-regulatory partners at different target loci, and the signal transduction pathway linking SPC to GATAD1 nuclear translocation remain undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No ChIP-seq or CUT&RUN genome-wide binding data reported\",\n        \"No crystal structure or cryo-EM of GATAD1 bound to modified histones\",\n        \"Upstream signaling from SPC to GATAD1 nuclear import is mechanistically uncharacterized\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [3, 4, 5, 6, 8]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 4, 5, 6, 8]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CCND1\",\n      \"CDKN1A\",\n      \"SRRM2\",\n      \"CD36\",\n      \"RAB6A\",\n      \"TBC1D11\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}